Cargando…

β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells

Our previous data illustrated that activation of the canonical Wnt signaling pathway was enriched in triple-negative breast cancer and associated with reduced overall survival in all patients. To determine whether Wnt signaling may be a promising therapeutic target for triple-negative breast cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jinhua, Prosperi, Jenifer R., Choudhury, Noura, Olopade, Olufunmilayo I., Goss, Kathleen H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319896/ https://www.ncbi.nlm.nih.gov/pubmed/25658419 http://dx.doi.org/10.1371/journal.pone.0117097

Ejemplares similares

APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology
por: Odenwald, Matthew A, et al.
Publicado: (2013)

Proteins Found in the Triple-Negative Breast Cancer Secretome and Their Therapeutic Potential
por: McHenry, Peter R., et al.
Publicado: (2023)

Combating CHK1 resistance in triple negative breast cancer: EGFR inhibition as potential combinational therapy
por: Stefanski, Casey D., et al.
Publicado: (2022)

Inhibiting β-catenin disables nucleolar functions in triple-negative breast cancer
por: Weeks, Shannon E., et al.
Publicado: (2021)

Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancer
por: Wu, Nan, et al.
Publicado: (2018)

Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer
por: Ryu, Won-Ji, et al.
Publicado: (2020)

Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma
por: Cole, Jennifer M., et al.
Publicado: (2019)

SHP2 Potentiates the Oncogenic Activity of β-Catenin to Promote Triple-Negative Breast Cancer
por: Martin, Elisha, et al.
Publicado: (2021)

The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
por: Wang, Wei, et al.
Publicado: (2023)

Short-Term Environmental Conditioning Enhances Tumorigenic Potential of Triple-Negative Breast Cancer Cells
por: Eckley, Samantha S., et al.
Publicado: (2019)

Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer
por: Gangrade, Abhishek, et al.
Publicado: (2018)

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2018)

Wnt/β-Catenin Inhibition Disrupts Carboplatin Resistance in Isogenic Models of Triple-Negative Breast Cancer
por: Abreu de Oliveira, Willy Antoni, et al.
Publicado: (2021)

CUEDC2 Drives β-Catenin Nuclear Translocation and Promotes Triple-Negative Breast Cancer Tumorigenesis
por: Han, Shuyan, et al.
Publicado: (2022)

LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women
por: Torres-Luquis, Odalys, et al.
Publicado: (2018)

An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer
por: Han, Yoo Jane, et al.
Publicado: (2022)

MicroRNA-139 Suppresses the Tumorigenicity of Triple Negative Breast Cancer Cells by Targeting SOX8
por: Dong, Liangliang, et al.
Publicado: (2020)

Countering Triple Negative Breast Cancer via Impeding Wnt/β-Catenin Signaling, a Phytotherapeutic Approach
por: Arzi, Laleh, et al.
Publicado: (2022)

Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer
por: Kourtidis, Antonis, et al.
Publicado: (2015)

No major tumorigenic role for β-catenin in serrated as opposed to conventional colorectal adenomas
por: Yamamoto, T, et al.
Publicado: (2003)

Development and characterization of two human triple‐negative breast cancer cell lines with highly tumorigenic and metastatic capabilities
por: Su, Yanrong, et al.
Publicado: (2016)

WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer
por: Wend, Peter, et al.
Publicado: (2013)

Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling
por: Yin, Lina, et al.
Publicado: (2016)

LGR6 Promotes Tumor Proliferation and Metastasis through Wnt/β-Catenin Signaling in Triple-Negative Breast Cancer
por: Kong, Yanan, et al.
Publicado: (2020)

Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression
por: Huang, Tzu-Ting, et al.
Publicado: (2020)

Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells
por: Ozawa, Patricia Midori Murobushi, et al.
Publicado: (2018)

Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences
por: Tayyari, Fariba, et al.
Publicado: (2018)

MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer
por: Tan, Zhanyao, et al.
Publicado: (2016)

New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
por: Khaled, Noura, et al.
Publicado: (2019)

Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer
por: Ma, Ji, et al.
Publicado: (2020)

Doing better and being better in breast cancer care: an interview with Funmi Olopade
por: Olopade, Olufunmilayo I.
Publicado: (2021)

The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer
por: Fatima, Iram, et al.
Publicado: (2017)

Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
por: Shen, Honghong, et al.
Publicado: (2019)

Role of microRNA/lncRNA Intertwined With the Wnt/β-Catenin Axis in Regulating the Pathogenesis of Triple-Negative Breast Cancer
por: Hu, Xue, et al.
Publicado: (2022)

Interference KRT17 reverses doxorubicin resistance in triple-negative breast cancer cells by Wnt/β-catenin signaling pathway
por: Wu, Liqiong, et al.
Publicado: (2023)

Apc Mutation Enhances PyMT-Induced Mammary Tumorigenesis
por: Prosperi, Jenifer R., et al.
Publicado: (2011)

GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway
por: Mao, Yingge, et al.
Publicado: (2019)

MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway
por: Zhou, Wei, et al.
Publicado: (2015)

Effect of MUC1/β-catenin interaction on the tumorigenic capacity of pancreatic CD133(+) cells
por: Sousa, Andreia Mota, et al.
Publicado: (2016)

Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner
por: Dey, Nandini, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hf906jep41drh64p51jh4cc4v3